MANHATTAN — The Second Circuit upheld the dismissal of a consumer lawsuit alleging Pfizer failed to warn that the drug Lipitor carries a risk of type 2 diabetes, finding that the claims are preempted by federal law and untimely.
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.


